Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
INTERCEPT PHARMACEUTICALS, INC. | SVP, IR & Corp. Affairs | Common Stock | 10.3K | $196K | $19.00 | Dec 31, 2021 | Direct |
LEXICON PHARMACEUTICALS, INC. | VP, IR and Corp Strategy | Common Stock | 0 | $0 | $2.62 | Oct 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LXRX | LEXICON PHARMACEUTICALS, INC. | Oct 2, 2024 | 0 | $0 | 3 | Oct 7, 2024 | VP, IR and Corp Strategy |
ICPT | INTERCEPT PHARMACEUTICALS, INC. | Dec 31, 2021 | 1 | -$8.83K | 4 | Jan 4, 2022 | SVP, IR & Corp. Affairs |
ICPT | INTERCEPT PHARMACEUTICALS, INC. | Sep 30, 2021 | 1 | -$3.03K | 4 | Oct 4, 2021 | SVP, IR & Corp. Affairs |
ICPT | INTERCEPT PHARMACEUTICALS, INC. | Sep 1, 2021 | 1 | -$8.1K | 4 | Sep 3, 2021 | SVP, IR & Corp. Affairs |